| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/08/2013 | CN103083471A Cortex lycii radicis Chinese medical herb and brewing method thereof |
| 05/08/2013 | CN103083470A Balsam pear and kudzu root slice with functions of decreasing blood sugar |
| 05/08/2013 | CN103083461A Medicine composition for treating diabetes |
| 05/08/2013 | CN103083440A Multi-functional natural healthcare product |
| 05/08/2013 | CN103083429A Blood fat-reducing traditional Chinese medicine formula |
| 05/08/2013 | CN103083423A Traditional Chinese prescription for treating hyperglycemia and preparation method thereof |
| 05/08/2013 | CN103083405A 'Sea-buckthorn and lotus leaf composite concentrate' product for reducing concentration of lipoprotein (a) in plasma |
| 05/08/2013 | CN103083403A Herbal composition for lowering likelihood of stroke and methods for healing stroke patients |
| 05/08/2013 | CN103083402A Traditional Chinese medicine composition for treating cholesterol-caused angiosclerosis |
| 05/08/2013 | CN103083377A Giant salamander bone calcium tablet and preparation method thereof |
| 05/08/2013 | CN103083370A Novel application of total flavones of hippophae rhamnoides |
| 05/08/2013 | CN103083362A Multipurpose functional water and preparation method thereof |
| 05/08/2013 | CN103083358A Vitamin D-containing calcium preparation and preparation method thereof |
| 05/08/2013 | CN103083355A Compound sodium chloride injection and preparation method thereof |
| 05/08/2013 | CN103083351A Pharmaceutical composite preparation of water-soluble vitamin for injection and fat-soluble vitamin injection |
| 05/08/2013 | CN103083322A Medicinal composition containing injection cefmenoxime hydrochloride and compound amino acid injection |
| 05/08/2013 | CN103083318A Bilayer tablet comprising telmisartan and amlodipine |
| 05/08/2013 | CN103083309A Application of sciadopitysin in preparation of medicines for prevention and treatment of diabetes |
| 05/08/2013 | CN103083307A Fused cyclic compounds |
| 05/08/2013 | CN103083280A Vitamin C soft capsules |
| 05/08/2013 | CN103083279A Polysaccharide sulfate soft capsule |
| 05/08/2013 | CN103083276A Rapidly disintegrated vitamin C effervescent tablet and preparation method thereof |
| 05/08/2013 | CN103083275A Enteric coated tablet of fenofibric acid and physiologically acceptable salts and preparation method of enteric coated tablet |
| 05/08/2013 | CN103083270A Xanthophyll chewable tablet |
| 05/08/2013 | CN103083269A Dropping pills containing mannose ester and preparation method thereof |
| 05/08/2013 | CN103083268A Polysaccharide sulfate dispersible tablet |
| 05/08/2013 | CN103083267A Polysaccharide sulfate chewable tablet |
| 05/08/2013 | CN103083261A Polysaccharide sulfate freeze-dried powder injection |
| 05/08/2013 | CN103083249A Method for preparing berberine chitosan drug-carrying microsphere by salting-out process |
| 05/08/2013 | CN103083248A Polysaccharide sulfate dry suspension |
| 05/08/2013 | CN103083241A Preparation method of fat-soluble vitamin nanoparticle |
| 05/08/2013 | CN103083235A Myricetin nanosuspension and preparation method thereof |
| 05/08/2013 | CN103083230A Fructose-containing injection and preparation method thereof |
| 05/08/2013 | CN103083226A Preparation of gel containing fibroblast growth factor-1 modified body and application thereof for treating diabetic foot |
| 05/08/2013 | CN103082296A Dietary supplement for reducing attacking of myocardial infarction |
| 05/08/2013 | CN103082292A Application of Roseburia to treatment and prevention of obesity related disease |
| 05/08/2013 | CN103081893A Myocardial cell traditional Chinese medicine preservation solution and application thereof |
| 05/08/2013 | CN102657663B Fat-soluble composite vitamin I composition freeze-dried powder injection and preparation method thereof |
| 05/08/2013 | CN102657662B Fat-soluble composite vitamin II composition freeze-dried powder injection and preparation method thereof |
| 05/08/2013 | CN102525945B Preparation method for cyclocarya paliurus(Batal)Ijinskaja hypoglycemic granules |
| 05/08/2013 | CN102450718B Pulse sports beverage and preparation method thereof |
| 05/08/2013 | CN102366480B Medicine for treating diabetes and preparation method thereof |
| 05/08/2013 | CN102335222B Pharmaceutical composition for adjusting blood fat and preparation process thereof |
| 05/08/2013 | CN102319341B Chinese medicinal compound for treating and preventing diabetes |
| 05/08/2013 | CN102309607B Chinese medicine decoction for treating diabetic retinopathy and preparation method thereof |
| 05/08/2013 | CN102308941B Diet green coarse cereal food and preparation method thereof |
| 05/08/2013 | CN102274184B Alprostadil liposome composite medicine and industrial preparation, quality control and use |
| 05/08/2013 | CN102242070B Method for artificially culturing paecilomyces cicadae and application of culturing product thereof |
| 05/08/2013 | CN102088965B Salicylate conjugates useful for treating metabolic disorders |
| 05/08/2013 | CN102070657B Bis-o-vanillin ethylene diamine schiff base and transitional metal coordination compound and preparation method thereof |
| 05/08/2013 | CN101821236B Five-membered heterocyclic compound |
| 05/08/2013 | CN101766228B Iimmune stimulatory infant nutrition |
| 05/08/2013 | CN101613284B Lovastatin, simvastatin and simvastatin-6-oxide nitro-oxo-derivative and preparation method thereof |
| 05/08/2013 | CN101560546B Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha |
| 05/08/2013 | CN101257914B Composition for amelioration of body lipid |
| 05/08/2013 | CN101254300B Intestinotrophic glucagon-like peptide-2 analogs |
| 05/08/2013 | CN101252834B Plasma-depleted, non-red blood cell-depleted umbilical cord blood compositions and methods of use |
| 05/08/2013 | CN101199301B Hubei Chinese flowering crabapple tea and preparation method and application of extractive thereof |
| 05/08/2013 | CN101128213B Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 05/07/2013 | US8436167 Chemical compounds |
| 05/07/2013 | US8436025 Compounds and methods for PKC theta inhibition |
| 05/07/2013 | US8435945 GH secretagogues and uses thereof |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/07/2013 | CA2702710C Trans-clomiphene for metabolic syndrome |
| 05/07/2013 | CA2647988C Interleukin production regulator, pharmaceutical composition, food, and drink containing interleukin production regulator, and production method thereof |
| 05/07/2013 | CA2558029C Ion binding polymers and uses thereof |
| 05/07/2013 | CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/07/2013 | CA2491131C Novel compounds as histone deacetylase inhibitors |
| 05/07/2013 | CA2397030C Methods for treating pancreatic disorders |
| 05/02/2013 | WO2013063527A1 Oral formulations mimetic of roux-en-y gastric bypass actions on the ileal brake; compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and t2d |
| 05/02/2013 | WO2013063389A2 Methods and compositions for treating diabetes and other degenerative neuroendocrine diseases or disorders |
| 05/02/2013 | WO2013063221A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid |
| 05/02/2013 | WO2013063049A1 Orally-administered plastid expressed cholera toxin b subunit-exendin 4 as treatment for type 2 diabetes |
| 05/02/2013 | WO2013063004A1 Device and method for sustained release of therapeutic agent |
| 05/02/2013 | WO2013062835A1 Substituted piperidinyl compounds useful as gpr119 agonists |
| 05/02/2013 | WO2013062570A1 Apparatus and method for producing controlled dosage of bioactive agent |
| 05/02/2013 | WO2013062294A2 Improved preparation method for mitiglinide calcium |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013061962A1 Bicyclic compound |
| 05/02/2013 | WO2013061455A1 Novel resveratrol polymerization compound or pharmaceutically acceptable salt thereof |
| 05/02/2013 | WO2013061106A1 Modified peptide toxins |
| 05/02/2013 | WO2013060860A1 N-acyl-n'-phenylpiperazine derivatives as srbp modulators for use in the treatment of diabetes and obesity |
| 05/02/2013 | WO2013060850A1 Treatment protocol of diabetes type 2 |
| 05/02/2013 | WO2013060653A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | WO2013060179A1 Acyltetrahydro-β-carboline compounds as well as derivatives, applications and preparation methods thereof |
| 05/02/2013 | WO2013025984A3 Cannabinoid receptor treatments |
| 05/02/2013 | WO2012174262A9 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations |
| 05/02/2013 | US20130109718 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes |
| 05/02/2013 | US20130109668 Azetidine compounds, compositions and methods of use |
| 05/02/2013 | US20130109649 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | US20130108694 Dry blend formulation of tetrahydrobiopterin |
| 05/02/2013 | US20130108672 Pharmaceutical compositions for substituted quinazolinones |
| 05/02/2013 | US20130108656 Peptide and method for reducing the phosphate requirement and excretion from farm animals |
| 05/02/2013 | US20130108615 Date Pit Composition For The Treatment Of Animals |
| 05/02/2013 | US20130108586 Composition and method of delivery of l-arabinose and select compounds |
| 05/02/2013 | CA2853455A1 Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid |
| 05/02/2013 | CA2853373A1 Antisense modulation of gccr expression |
| 05/02/2013 | CA2853347A1 Device and method for sustained release of therapeutic agent |
| 05/02/2013 | CA2853221A1 Bicyclic compound |
| 05/02/2013 | CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity |